Articles

Podcasts

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

During this video interview, Dr. Jay Mehta talks about his approach to explaining such complex medical conditions and treatments to his pediatric patients and their families. 

Jay Mehta, MD, MSEd: Explaining Pediatric Rheumatologic Lab Results

Dr. Mehta talks about rheumatologic testing, joint examinations, and the great relationships he gets to develop with his patients. 

Jay Mehta, MD, MSEd: Sharing his Passion for Pediatric Rheumatology

Dr. Mehta highlights some of the challenges that come with treating pediatric rheumatology patients and how he handles them. 

Jay Mehta, MD, MSEd: Understanding Pediatric Rheumatologic Lab Results

In this video interview, Dr. Jay Mehta discusses his presentation on pediatric rheumatology for the American Association of Pediatrics Conference. 

Jay Mehta, MD, MSEd: Rheumatologic Lab Evaluation of Musculoskeletal Pain

The 2 studies focused on upadacitinib treatment for one group of patients with ankylosing spondylitis and another group of patients with non-radiographic axial spondyloarthritis.

Upadacitinib Phase 3 Clinical Trials Meet Primary and Most Ranked Secondary Endpoints

Looking specifically at patients who have been treated with biologic disease-modifying anti-rheumatic drugs, this study examines the risk of new or recurrent cancer.

Systematic Review Assesses the Risk of Cancer in Rheumatoid Arthritis Patients

Investigators analyze the differences between SARS-CoV-2 testing and risk of infection.

Testing and Risk of COVID-19 in Patients with Immune Mediated Inflammatory Disease

Investigators found no significant differences in the efficacy and safety of the originator or biosimilars in children with juvenile idiopathic arthritis.

Etancercept and Biosimilars Recommended for Treatment of JIA

Investigators gathered data from vulnerable populations with rheumatic disease regarding their thoughts and opinions on the COVID-19 virus.

Investigation Confirms COVID-19 Concerns in People with Rheumatic Disease

Dr. Blauvelt speaks on the results of the phase 3b Heads Up study, and the future of upadacitinib and dupilumab in atopic dermatitis management.

Andrew Blauvelt, MD, MBA: The “New Era” of Dermatological Drugs

The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.